BridgeBio Pharma Inc. trailing returns
How BridgeBio Pharma Inc. (BBIO) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-10-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +0.5% | |
| 5 days | — | +2.6% | |
| 1 month | — | -12.1% | |
| YTD | — | -12.1% | |
| 1 year | +26.2% | +26.2% | |
| 5 years | +7.1% | +40.9% | |
| Since inception (2019) | +13.1% | +144.1% |
Growth of BBIO
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from BBIO's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is BridgeBio Pharma Inc.'s return since inception?
- Since 2019, BridgeBio Pharma Inc. (BBIO) has compounded at about +13.1% a year — +144.1% in total.